Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Schrimpf

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
Acta Neuropathologica|December 17, 2015
Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targetsFelix Sahm, Daniel Schrimpf, David T W Jones, et al.
Acta Neuropathologica|March 31, 2022
Rapid-CNS<sup>2</sup>: rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof-of-concept studyAreeba Patel, Helin Dogan, Alexander Payne, et al.
Acta Neuropathologica|August 11, 2020
Infratentorial IDH-mutant astrocytoma is a distinct subtypeRouzbeh Banan, Damian Stichel, Anja Bleck, et al.
Acta Neuropathologica|July 10, 2020
CDKN2A/B homozygous deletion is associated with early recurrence in meningiomasPhilipp Sievers, Thomas Hielscher, Daniel Schrimpf, et al.
Acta Neuropathologica|January 27, 2017
Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivoStefan Pusch, Sonja Krausert, Viktoria Fischer, et al.
Acta Neuropathologica|May 6, 2017
Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signatureFelix Sahm, Umut H Toprak, Daniel Hübschmann, et al.
Acta Neuropathologica|July 4, 2018
Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experienceDavid Capper, Damian Stichel, Felix Sahm, et al.
Nature Communications|March 25, 2023
Genomic characterization of DICER1-associated neoplasms uncovers molecular classesFelix K F Kommoss, Anne-Sophie Chong, Anne-Laure Chong, et al.
Acta Neuropathologica|July 18, 2024
Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterationsPhilipp Sievers, Franck Bielle, Kirsten Göbel, et al.
Acta Neuropathologica|September 18, 2021
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma typesPhilipp Sievers, Damian Stichel, Martin Sill, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Acta Neuropathologica|December 17, 2015
Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targetsFelix Sahm, Daniel Schrimpf, David T W Jones, et al.
Acta Neuropathologica|March 31, 2022
Rapid-CNS<sup>2</sup>: rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof-of-concept studyAreeba Patel, Helin Dogan, Alexander Payne, et al.
Acta Neuropathologica|August 11, 2020
Infratentorial IDH-mutant astrocytoma is a distinct subtypeRouzbeh Banan, Damian Stichel, Anja Bleck, et al.
Acta Neuropathologica|July 10, 2020
CDKN2A/B homozygous deletion is associated with early recurrence in meningiomasPhilipp Sievers, Thomas Hielscher, Daniel Schrimpf, et al.
Acta Neuropathologica|January 27, 2017
Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivoStefan Pusch, Sonja Krausert, Viktoria Fischer, et al.
Acta Neuropathologica|May 6, 2017
Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signatureFelix Sahm, Umut H Toprak, Daniel Hübschmann, et al.
Acta Neuropathologica|July 4, 2018
Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experienceDavid Capper, Damian Stichel, Felix Sahm, et al.
Nature Communications|March 25, 2023
Genomic characterization of DICER1-associated neoplasms uncovers molecular classesFelix K F Kommoss, Anne-Sophie Chong, Anne-Laure Chong, et al.
Acta Neuropathologica|July 18, 2024
Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterationsPhilipp Sievers, Franck Bielle, Kirsten Göbel, et al.
Acta Neuropathologica|September 18, 2021
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma typesPhilipp Sievers, Damian Stichel, Martin Sill, et al.
Pageof 13